181 related articles for article (PubMed ID: 9088864)
1. Effects of metrifonate on memory impairment and cholinergic dysfunction in rats.
Itoh A; Nitta A; Katono Y; Usui M; Naruhashi K; Iida R; Hasegawa T; Nabeshima T
Eur J Pharmacol; 1997 Mar; 322(1):11-9. PubMed ID: 9088864
[TBL] [Abstract][Full Text] [Related]
2. Effects of metrifonate on impairment of learning and dysfunction of cholinergic neuronal system in basal forebrain-lesioned rats.
Itoh A; Nitta A; Hirose M; Hasegawa T; Nabeshima T
Behav Brain Res; 1997 Feb; 83(1-2):165-7. PubMed ID: 9062677
[TBL] [Abstract][Full Text] [Related]
3. Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats.
Riekkinen P; Schmidt B; Stefanski R; Kuitunen J; Riekkinen M
Eur J Pharmacol; 1996 Aug; 309(2):121-30. PubMed ID: 8874130
[TBL] [Abstract][Full Text] [Related]
4. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.
Scali C; Giovannini MG; Bartolini L; Prosperi C; Hinz V; Schmidt B; Pepeu G
Eur J Pharmacol; 1997 May; 325(2-3):173-80. PubMed ID: 9163564
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined nimodipine and metrifonate on rat cognition and cortical EEG.
Jäkälä P; Riekkinen M; Björklund M; Koivisto E; Schmidt B; Riekkinen P
Eur J Pharmacol; 1996 Dec; 318(2-3):239-50. PubMed ID: 9016911
[TBL] [Abstract][Full Text] [Related]
6. Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats.
Giovannini MG; Scali C; Bartolini L; Schmidt B; Pepeu G
Eur J Pharmacol; 1998 Jul; 354(1):17-24. PubMed ID: 9726626
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
[TBL] [Abstract][Full Text] [Related]
8. Effects of S-8510, a novel benzodiazepine receptor partial inverse agonist, on basal forebrain lesioning-induced dysfunction in rats.
Abe K; Takeyama C; Yoshimura K
Eur J Pharmacol; 1998 Apr; 347(2-3):145-52. PubMed ID: 9653874
[TBL] [Abstract][Full Text] [Related]
9. Anti-amnesic and anti-cholinesterase activities of α-asarone against scopolamine-induced memory impairments in rats.
Venkatesan K
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6344-6350. PubMed ID: 36111936
[TBL] [Abstract][Full Text] [Related]
10. Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.
Hinz V; Grewig S; Schmidt BH
Neurochem Res; 1996 Mar; 21(3):339-45. PubMed ID: 9139240
[TBL] [Abstract][Full Text] [Related]
11. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats.
Senda T; Matsuno K; Okamoto K; Kobayashi T; Nakata K; Mita S
Eur J Pharmacol; 1996 Nov; 315(1):1-10. PubMed ID: 8960858
[TBL] [Abstract][Full Text] [Related]
12. SDZ ENA 713 facilitates central cholinergic function and ameliorates spatial memory impairment in rats.
Ohara T; Tanaka K; Fukaya H; Demura N; Iimura A; Seno N
Behav Brain Res; 1997 Feb; 83(1-2):229-33. PubMed ID: 9062691
[TBL] [Abstract][Full Text] [Related]
13. Effects of combined chronic nimodipine and acute metrifonate treatment on spatial and avoidance behavior.
Riekkinen M; Schmidt B; Kuitunen J; Riekkinen P
Eur J Pharmacol; 1997 Mar; 322(1):1-9. PubMed ID: 9088863
[TBL] [Abstract][Full Text] [Related]
14. Effects of nefiracetam on amnesia animal models with neuronal dysfunctions.
Hiramatsu M; Shiotani T; Kameyama T; Nabeshima T
Behav Brain Res; 1997 Feb; 83(1-2):107-15. PubMed ID: 9062668
[TBL] [Abstract][Full Text] [Related]
15. Subchronic treatment increases the duration of the cognitive enhancement induced by metrifonate.
Riekkinen M; Schmidt BH; Riekkinen P
Eur J Pharmacol; 1997 Nov; 338(2):105-10. PubMed ID: 9455990
[TBL] [Abstract][Full Text] [Related]
16. Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats.
Fuji K; Hiramatsu M; Kameyama T; Nabeshima T
Eur J Pharmacol; 1993 Jun; 236(3):411-7. PubMed ID: 8359199
[TBL] [Abstract][Full Text] [Related]
17. Characterization of learning and memory behaviors and the effects of metrifonate in the C57BL strain of mice.
Ikonen S; Schmidt BH; Riekkinen P
Eur J Pharmacol; 1999 May; 372(2):117-26. PubMed ID: 10395091
[TBL] [Abstract][Full Text] [Related]
18. Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
Scali C; Casamenti F; Bellucci A; Costagli C; Schmidt B; Pepeu G
J Neural Transm (Vienna); 2002 Jul; 109(7-8):1067-80. PubMed ID: 12111444
[TBL] [Abstract][Full Text] [Related]
19. Potentiation by DSP-4 of EEG slowing and memory impairment in basal forebrain-lesioned rats.
Abe K; Horiuchi M; Yoshimura K
Eur J Pharmacol; 1997 Feb; 321(2):149-55. PubMed ID: 9063682
[TBL] [Abstract][Full Text] [Related]
20. The memory ameliorating effects of INM-176, an ethanolic extract of Angelica gigas, against scopolamine- or Aβ(1-42)-induced cognitive dysfunction in mice.
Park SJ; Jung JM; Lee HE; Lee YW; Kim DH; Kim JM; Hong JG; Lee CH; Jung IH; Cho YB; Jang DS; Ryu JH
J Ethnopharmacol; 2012 Sep; 143(2):611-20. PubMed ID: 22846435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
